INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE

被引：0
|
作者：
Al Awadi, F. [1 ]
Aly, H. [2 ]
Bashier, A. [1 ]
Benavente, J. Medina [3 ]
Dhanwal, D. Kumar [4 ]
Jallo, M. [5 ]
Singhal, S. [6 ]
Abusnana, S. [7 ]
机构：
[1] Dubai Hosp, Endocrinol, Dubai, U Arab Emirates
[2] Novo Nordisk Pharmaceut Co, Clin Med Regulatory Affairs & Qual, Dubai, U Arab Emirates
[3] Novo Nordisk AS, Endocrinol, Soborg, Denmark
[4] NMC Specialty Hosp, Endocrinol, Abu Dhabi, U Arab Emirates
[5] Gulf Med Univ, Coll Med, Clin Sci, Ajman, U Arab Emirates
[6] Novo Nordisk, Clin Med Regulatory Affairs & Qual, Dubai, U Arab Emirates
[7] Univ Sharjah, Endocrinol, Sharjah, U Arab Emirates
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2022年 / 186卷
关键词：
D O I：
10.1016/j.diabres.2022.109620
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF21-0679
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    DIABETOLOGIA, 2014, 57 : S440 - S440
  • [22] Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec-Liraglutide (Ideglira)
    Zenari, Luciano
    Da Porto, Andrea
    De Moliner, Lorena
    Lugli, Francesca
    Guazzoni, Valeria
    Groppelli, Gloria
    Molteni, Laura
    Bracaccia, Massimo
    Frison, Vera
    Simioni, Natalino
    Bonsembiante, Barbara
    Miranda, Cesare
    Lapolla, Annunziata
    DIABETES THERAPY, 2021, 12 (01) : 197 - 209
  • [23] Therapeutically Exchangeable? A Real-World Outcome Study of Switching between Basal Insulin Analogs among T2DM Patients
    Levin, Philip
    Wei, Wenhui
    Miao, Raymond
    Xie, Lin
    Ye, Fen
    Baser, Onur
    Gill, Jasvinder K.
    DIABETES, 2014, 63 : A234 - A234
  • [24] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
    Galstyan, G.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M.
    Quan, J.
    Pilorget, V.
    Cherkasov, D.
    Naqvi, M.
    Khan, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
  • [25] Impact of Diabetes Treatment-Related Attributes on Costs of Type 2 Diabetes (T2DM) Patients in a Real-World Population
    Lee, Yi-Chien
    Meng, Jie
    Casciano, Roman
    Perrin, Allison
    Gultyaev, Dmitry
    Tong, Liyue
    Kitio-Dschassi, Brice
    DIABETES, 2016, 65 : A323 - A323
  • [26] Real-World Study of Delayed Initiation of Insulin and Associated Factors Among Elderly Patients With Type 2 Diabetes Mellitus (T2DM)
    Bhattacharya, Rituparna
    Zhou, Steve
    Wei, Wenhui
    Ajmera, Mayank
    Ling, John
    Sambamoorthi, Usha
    DIABETES, 2013, 62 : A323 - A323
  • [27] Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting
    Jendle, J. H.
    Thunander, M.
    Sjoberg, S.
    Ekman, B.
    Mardby, A. -C.
    Fernandes, J. Da Rocha
    Gundgaard, J.
    Ericsson, A.
    DIABETOLOGIA, 2019, 62 : S436 - S436
  • [28] A Real-World Evidence in Understanding the Barriers and Behaviours of Insulin Therapy among Indian Type 2 Diabetes Mellitus (T2DM) Patients
    Raj, Praveen
    Pawar, Dilip
    Jabeen, Sarah
    Shivaram, V. S.
    DIABETES, 2018, 67
  • [29] Novel Use of Natural Language Processing to Identify Reasons for Insulin Discontinuation in Patients with T2DM: A Real-World Evidence Study
    Wu, Jianmin
    Morrison, Fritha J.
    Zhao, Zhenxiang
    He, Xuanyao
    Shubina, Maria
    Malmasi, Shervin
    Ge, Wendong
    Peng, Xiaomei
    Turchin, Alexander
    DIABETES, 2019, 68
  • [30] Real-World Practice Pattern and Outcomes of Patients With Type 2 Diabetes (T2DM) Initiating Injectable Therapy via Insulin Glargine Disposable Pen (GLA-P) or Liraglutide (LIRA)
    Lin, Jay
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    Levin, Philip
    DIABETES, 2012, 61 : A286 - A286
12345